1. Incretin Therapies: Effects Beyond Glycemic Control
Sunder Mudaliar, MD, Robert R. Henry, MD 
The American Journal of Medicine 
Volume 122, Issue 6, Pages S25-S36 (June 2009)
DOI: /j.amjmed
Copyright © Terms and Conditions

2. Figure 1
Glycemic and extraglycemic effects of incretins/glucagonlike peptide–1 (GLP-1) agents. BP = blood pressure; CNS = central nervous system; GI = gastrointestinal.
*Mediated centrally.
The American Journal of Medicine  , S25-S36DOI: ( /j.amjmed )
Copyright © Terms and Conditions